Inventor
Grayson Walker Stowell
Inventor
Wilmington, NC, US
Overview
Patents· 43 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds21%
Y10TTechnical subjects covered by former us classification8%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
A61MDevices for introducing media into, or onto, the body5%
C07CAcyclic or carbocyclic compounds4%
C07KPeptides3%
PatentTitleYear
10,772,883Diketopiperazine microparticles with defined specific surface areas202010,603,383High capacity diketopiperazine microparticles and methods202010,376,587High capacity diketopiperazine microparticles and methods201910,258,664Methods and compositions for treating pain201910,130,709High capacity diketopiperazine microparticles and methods20189,630,930'Diketopiperazine microparticles with defined specific surface areas'20179,610,351'Methods and compositions for treating pain'20179,364,436'High capacity diketopiperazine microparticles and methods'20169,233,159'Methods and compositions for treating pain'20168,785,396'Method and composition for treating migraines'20148,778,403'Diketopiperazine microparticles with defined specific surface areas'20148,734,845'Diketopiperazine microparticles with defined specific surface areas'20148,642,548'Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome'20148,551,528'Diketopiperazine microparticles with defined specific surface areas'20136,780,880'FT-Raman spectroscopic measurement'20046,706,737'Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'20046,673,936'Process for purifying 6-methoxy omeprazole'20046,667,321'Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'20036,667,323'Dry-blend pharmaceutical formulations'20036,667,324'Dry blend pharmaceutical formulations'20036,660,864'Polymorphic forms of 6-4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy-3,4-dihydro-2(1H)-quinolinone'20036,657,061'Polymorphic forms of 6-4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy-3,4-dihydro-2(1H)-quinolinone'20036,653,329'Granulated pharmaceutical formulations and methods for making the same'20036,608,091'Process for purifying 6-methoxy omeprazole'20036,596,871'Polymorphic forms of 6-4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy-3,4-dihydro-2(1H)-quinolinone'20036,573,382'Polymorphic forms of 6-4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy-3,4-dihydro-2(1H)-quinolinone'20036,531,603'Polymorphic forms of 6-4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy-3,4-dihydro-2(1H)-quinolinone'20036,492,556'Form A of fluoxetine hydrochloride'20026,444,689'Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'20026,388,080'Polymorphic forms of 6-4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy-3,4-dihydro-2(1H)-quinolinone'20026,369,087'Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'20026,326,384'Dry blend pharmaceutical unit dosage form'20016,316,020'Pharmaceutical formulations'20016,316,672'Form a of fluoxetine hydrochloride'20016,312,723'Pharmaceutical unit dosage form'20016,313,350'Form a of fluoxetine hydrochloride'20016,312,712'Method of improving bioavailability'20016,310,250'Form A of fluoxetine hydrochloride'20016,310,251'Form a of fluoxetine hydrochloride'20016,268,385'Dry blend pharmaceutical formulations'20016,262,085'Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'20016,262,086'Pharmaceutical unit dosage form'20016,258,853'Form a of fluoxetine hydrochloride'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2004Based in Wilmington, NC, US· patent location history
2013–2020Patents assigned to MANNKIND CORP (14)· patent assignee history
2013–2016Patents assigned to STOWELL GRAYSON W (5)· patent assignee history
2013–2014Patents assigned to GRANT MARSHALL L (3)· patent assignee history
2013–2016Patents assigned to MENKIN PAUL (3)· patent assignee history
2013–2017Based in Gaylordsville, CT, US· patent location history
2014–2016Patents assigned to GRANT MARSHALL (2)· patent assignee history
2018–2020Based in Cary, NC, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MANNKIND CORP | 14 | 2013–2020 |
| STOWELL GRAYSON Wself | 5 | 2013–2016 |
| GRANT MARSHALL L | 3 | 2013–2014 |
| MENKIN PAUL | 3 | 2013–2016 |
| GRANT MARSHALL | 2 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Wilmington, NC, US | 29 | 2001–2004 |
| Gaylordsville, CT, US | 9 | 2013–2017 |
| Cary, NC, US | 5 | 2018–2020 |